Plus Therapeutics shares owned by UBS Group
Historical chart of UBS Group investment in Plus Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Plus Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Plus Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $427k | 624k | 0.68 |
| 2025-06-30 | $31k | 88k | 0.35 |
| 2025-03-31 | $32k | 33k | 0.95 |
| 2024-06-30 | $4.7k | 3.2k | 1.47 |
| 2023-12-31 | $16k | 8.9k | 1.75 |
| 2023-09-30 | $6.9k | 5.1k | 1.34 |